Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Sica

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Archives of Dermatology|July 21, 2010
Centipede bite: a case reportStefano Veraldi, Anna Chiaratti, Lorenzo Sica
Tumori|February 8, 2014
Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options availableGiulia Valeria Bianchi, Matteo Duca, Lorenzo Sica, et al.
Tumori|February 8, 2014
Lapatinib and letrozole as first-line therapy for metastatic breast cancer: case report of bone metastasis 18 years laterGabriella Mariani, Francesca Ricchini, Lorenzo Sica, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
Frontiers in Oncology|March 26, 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practiceGiulia Notini, Matteo Maria Naldini, Lorenzo Sica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast CancerLucia Viganò, Alberta Locatelli, Adele Ulisse, et al.
The Oncologist|May 16, 2020
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 OutbreakGiulia Viale, Luca Licata, Lorenzo Sica, et al.
Cancer Treatment Reviews|January 22, 2026
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practiceIrene Persano, Luca Licata, Marta Piras, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Dermatology|July 21, 2010
Centipede bite: a case reportStefano Veraldi, Anna Chiaratti, Lorenzo Sica
Tumori|February 8, 2014
Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options availableGiulia Valeria Bianchi, Matteo Duca, Lorenzo Sica, et al.
Tumori|February 8, 2014
Lapatinib and letrozole as first-line therapy for metastatic breast cancer: case report of bone metastasis 18 years laterGabriella Mariani, Francesca Ricchini, Lorenzo Sica, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
Frontiers in Oncology|March 26, 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practiceGiulia Notini, Matteo Maria Naldini, Lorenzo Sica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast CancerLucia Viganò, Alberta Locatelli, Adele Ulisse, et al.
The Oncologist|May 16, 2020
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 OutbreakGiulia Viale, Luca Licata, Lorenzo Sica, et al.
Cancer Treatment Reviews|January 22, 2026
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practiceIrene Persano, Luca Licata, Marta Piras, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Pageof 1